Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Following the transfer of the Ordinary Shares referred to above.
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a) | ||
2 | Reason for the notification | |
a) | Position/status | Chief Executive Officer/PDMR |
b) | Initial notification/ Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | ||
b) | LEI | 213800SLDKXWKT6E3381 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of £0.02 each GB00BYWF9Y76 |
b) | Nature of the transaction | Allotment of Ordinary Shares following vesting of share award under the Company's Performance Share Plan |
c) | Price(s) and volume(s) | 75,000 Ordinary Shares at a price of £0.02 pence per share |
d) | Aggregated information - Aggregated volume - Price | N/A |
e) | Date of the transaction | |
f) | Place of the transaction | Euronext Brussels (XBRU) |
Contacts
+44 1223 919760 / +1 317 505 1280 IR@acaciapharma.com | International Media +44 20 7638 9571 acaciapharma@citigatedewerogerson.com |
US Investors +1 917-734-7387 ikoffler@lifesciadvisors.com | Media in +32 499 58 55 31 chrisvanraemdonck@telenet.be |
© OMX, source